(Q37610290)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19811029%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

title

Newer antipsychotics: comparative review of drug interactions (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19811029%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19811029%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

author name string

M G Scordo

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19811029%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

publication date

1 November 2001

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19811029%20AND%20SRC:MED&resulttype=core&format=json

Expert Review of Neurotherapeutics: a key contribution to decision making in the treatment of neurologic and neuropsychiatric disorders

9 February 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19811029%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

volume

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19811029%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

page(s)

171-182

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19811029%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19811029%20AND%20SRC:MED&resulttype=core&format=json

Atypical antipsychotics: are some more atypical than others?

9 February 2020

cites work

1 reference

https://api.crossref.org/works/10.1586%2F14737175.1.2.171

Selective serotonin reuptake inhibitors and CNS drug interactions. A critical review of the evidence

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.1.2.171

Drug metabolism and atypical antipsychotics

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.1.2.171

Risperidone compared with new and reference antipsychotic drugs: in vitro and in vivo receptor binding

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.1.2.171

Do novel antipsychotics have similar pharmacological characteristics? A review of the evidence

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.1.2.171

Will routine therapeutic drug monitoring have a place in clozapine therapy?

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.1.2.171

Pharmacokinetics of selective serotonin reuptake inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.1.2.171

Fluvoxamine Inhibition and Carbamazepine Induction of the Metabolism of Clozapine

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.1.2.171

Addition of low-dose fluvoxamine to low-dose clozapine monotherapy in schizophrenia: drug monitoring and tolerability data from a prospective clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.1.2.171

Effects of caffeine withdrawal from the diet on the metabolism of clozapine in schizophrenic patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.1.2.171

Carbamazepine-induced changes in plasma levels of neuroleptics

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.1.2.171

Inducing effect of phenobarbital on clozapine metabolism in patients with chronic schizophrenia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.1.2.171

Potential impact of valproic acid therapy on clozapine disposition.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.1.2.171

An evaluation of risperidone drug interactions

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.1.2.171

Relationship between plasma risperidone and 9-hydroxyrisperidone concentrations and clinical response in patients with schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.1.2.171

Lack of drug interactions between mirtazapine and risperidone in psychiatric patients: a pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.1.2.171

Olanzapine. Pharmacokinetic and pharmacodynamic profile.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.1.2.171

Quetiapine: a review of its safety in the management of schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.1.2.171

The effects of concomitant phenytoin administration on the steady-state pharmacokinetics of quetiapine

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.1.2.171

P450 superfamily: update on new sequences, gene mapping, accession numbers and nomenclature.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.1.2.171

21 January 2018

Identifiers

DOI

10.1586/14737175.1.2.171

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19811029%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

1 reference